Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04038970
What this trial is testing

Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 145
Not applicableNot Yet RecruitingNCT07331701
What this trial is testing

Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

Who this might be right for
Lung NeoplasmsTumor Immune Microenvironment
Seoul National University Hospital 60
Post-approval studies (Phase 4)Study completedNCT00385957
What this trial is testing

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 70
Large-scale testing (Phase 3)Study completedNCT00409838
What this trial is testing

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 113
Large-scale testing (Phase 3)Study completedNCT01235507
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Large-scale testing (Phase 3)Study completedNCT00810199
What this trial is testing

Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 556
Not applicableLooking for participantsNCT06599411
What this trial is testing

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Who this might be right for
Atopic DermatitisPsoriasisHidradenitis Suppurativa+9 more
Assistance Publique - Hôpitaux de Paris 830
Not applicableUnknownNCT02502539
What this trial is testing

Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases

Who this might be right for
Juvenile Idiopathic Arthritis
University Hospital, Clermont-Ferrand 20
Not applicableWithdrawnNCT02786563
What this trial is testing

Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie
Large-scale testing (Phase 3)Study completedNCT06020144
What this trial is testing

Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs

Who this might be right for
Rheumatoid Arthritis
Hangzhou Highlightll Pharmaceutical Co., Ltd 459
Testing effectiveness (Phase 2)Study completedNCT00413660
What this trial is testing

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 509
Testing effectiveness (Phase 2)Study completedNCT00292422
What this trial is testing

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 50
Early research (Phase 1)Not Yet RecruitingNCT07688369
What this trial is testing

Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults

Who this might be right for
Polio Immunity
Serum Institute of India Pvt. Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT05462106
What this trial is testing

Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Who this might be right for
Amyloid PlaqueBeta-AmyloidDSAD+2 more
AC Immune SA 304
Not applicableStudy completedNCT05914532
What this trial is testing

New Biomarkers in Axial Sypondyloarthropathy; SII and SIRI

Who this might be right for
Axial Spondyloarthritis
Istanbul Training and Research Hospital 155
Testing effectiveness (Phase 2)Study completedNCT02996500
What this trial is testing

Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 269
Not applicableNot Yet RecruitingNCT07685509
What this trial is testing

Achilles Tendinopathy; the Effect of Shockwave Treatment

Who this might be right for
Achilles Tendinopathy (AT)Achilles TendonAchilles Tendon Pain
Vastra Gotaland Region 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Early research (Phase 1)Study completedNCT01921777
What this trial is testing

Effects of Traumeel®S Tablets on Recovery and Inflammatory Immune Response After Repeated Bouts of Exercise

Who this might be right for
Exercise-induced Muscle Soreness
Prof. Dr. med. Frank Christoph Mooren 95
Large-scale testing (Phase 3)Study completedNCT01565577
What this trial is testing

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)

Who this might be right for
Vaccination With MenbVac
University Hospital, Rouen 117
Next Page